Showing results (411-420 of 600) with videos related to
Sort By:
Pageof 60
Fertility and Sterility|July 19, 2011
How can macroscopically normal peritoneum contribute to the pathogenesis of endometriosis?Amelie Fassbender, Lut Overbergh, Eefje Verdrengh, et al.Proteomics. Clinical Applications|December 8, 2010
Protein-induced changes during the maturation process of human dendritic cells: A 2-D DIGE approachGabriela Bomfim Ferreira, Lut Overbergh, Evelyne van Etten, et al.Nutrition and Health|April 3, 2023
Change in carbohydrate intake one year after Roux-en-Y gastric bypass: A prospective studyJoke Vliebergh, Ina Gesquiere, Veerle Foulon, et al.BMJ Open|January 13, 2018
Transvaginal natural orifice transluminal endoscopic surgery (vNOTES) adnexectomy for benign pathology compared with laparoscopic excision (NOTABLE): a protocol for a randomised controlled trialJan Filip Baekelandt, Peter A De Mulder, Ilse Le Roy, et al.Proteomics|July 30, 2009
Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin DGabriela Bomfim Ferreira, Evelyne van Etten, Kasper Lage, et al.The Lancet. Diabetes & Endocrinology|June 7, 2025
Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trialChantal Mathieu, Francesco Giorgino, Sin Gon Kim, et al.Plos One|October 1, 2014
Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in miceLei Ding, Conny A Gysemans, Geert Stangé, et al.Clinical Immunology (Orlando, Fla.)|May 27, 2008
T-cell mediated late increase in bronchial tone after allergen provocation in a murine asthma modelIsabelle Meyts, Jeroen A Vanoirbeek, Greet Hens, et al.The Lancet. Diabetes & Endocrinology|June 7, 2026
Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a studyVanita R Aroda, Raffaella Buzzetti, Stine-Mathilde Dalskov, et al.Diabetes Technology & Therapeutics|July 2, 2026
Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World StudyAstrid Lavens, Jean-Christophe Philips, Christophe De Block, et al.Pageof 60